MOUNJARO - WHY? WHAT? HOW? - Dr. AMAR VENNAPUSA
YouTube Link -
https://youtu.be/D5Fk2IsZ9Q0
Eli Lilly has introduced Injection Mounjaro in India for the treatment of obesity and diabetes. The active ingredient in this injection is Tirzepatide.
In the United States, this molecule is marketed under two different brand names:
- Zepbound – for weight loss
- Mounjaro – for diabetes management
However, in India, Tirzepatide is available only under the brand name Mounjaro, regardless of whether it is used for weight loss or diabetes treatment.
So, how does Mounjaro work? Who is eligible to use it? What are the possible side effects? Let’s explore.
–
✍️
Dr. AMAR VENNAPUSA
Director, Bariatric & Metabolic Surgery,
Dr. Amar Bariatric & Metabolic Center
Jubille Hills
Hyderabad
🌏 www.drVamar.com
🎬 https://www.youtube.com/drVamar
🎯https://www.instagram.com/drVamar
📱+91 96 76 67 56 46
📱+91 99 89 79 78 68
#obesity
#diabetes
#tirzepatide
#mounjaro
#elililly
#lilly
#zepbound
#semaglutide
#wegovy
#ozempic
#weightlossmedications
#glp1
#gip
#glucagonlikepeptide1
#gastricinhibitorypeptide,
#glucosedependentinsulinotrophicpolypeptide
#type2diabetes
#weightloss
#weightlossjourney
#weightlossmotivation
#weightlosstips
#bariatriccommunity
#bariatriclife
#bariatricsleeve
#drvamar
#obesitysurgery
#rouxenygastricbypass
#minigastricbypass
#gastricsleevesurgery
#gastricsleevecommunity
#gastricsleevebeforeandafter
#hyderabad
#healthylifestyle
#healthy
#healthyfood
#nutrition
#nutritionfacts
#overweight












